多变量分片线性回归模型用于预测放射敏感性,使用与全基因组拷贝数变异的关联来预测放射敏感性
Joanna Tobiasz1,2, Najla Al-Harbi3, Sara Bin Judia3
1Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
Frontiers in oncology
|October 18, 2023
概括
这项研究开发了一种机器学习方法,使用副本数变异 (CNV) 来预测癌细胞的放射敏感性. 该方法确定了放射敏感细胞和放射耐药细胞的特定CNV标记物,有助于个性化放射治疗.
科学领域:
- 基因组学和生物信息学
- 辐射瘤学 辐射瘤学
- 癌症生物标志物 癌症生物标志物
背景情况:
- 预测患者对放射治疗的反应对于个性化癌症治疗和辐射风险评估至关重要.
- 全基因组拷贝数变异 (CNVs) 正被研究为放射敏感性的潜在生物标志物.
研究的目的:
- 开发一种机器学习方法,使用CNVs来分层放射敏感性.
- 为了确定与不同程度的对电离辐射敏感度相关的特定CNV.
主要方法:
- 利用Affymetrix CytoScan HD微阵列分析129个纤维细胞细胞株中的CNV.
- 通过2 Gy (SF2) 的幸存分数测量了辐射敏感性.
- 应用了一种动态编程 (DP) 算法,用于断片式多变量线性回归来预测SF2并识别相关的CNV.
主要成果:
- 该DP算法将细胞菌株细分为放射性敏感 (RS),正常敏感 (NS) 和耐辐射 (RR) 组.
- 一个5段模型确定了C-3SFBP (MCC基因区域) 作为RS细胞的标记物和C-7IUVU (SLC1A6基因区域) 作为RR细胞的标记物.
- 发现拷贝数量的减少通常与辐射敏感度的增加有关.
结论:
- 基于DP的方法有效地缩小了用于辐射敏感性预测的CNV标记.
- SF2分区改善了估计和识别不同的标记物,有助于对放射治疗进行剂量调整.
- 识别的CNV标志物可能通过识别那些从剂量减少或升级中受益的患者来指导个性化放射治疗.
相关概念视频
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357


